Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 259

1.

Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder.

Bridge JA, Birmaher B, Iyengar S, Barbe RP, Brent DA.

Am J Psychiatry. 2009 Jan;166(1):42-9. doi: 10.1176/appi.ajp.2008.08020247. Review.

PMID:
19047322
2.

A meta-analysis of early sustained response rates between antidepressants and placebo for the treatment of major depressive disorder.

Papakostas GI, Perlis RH, Scalia MJ, Petersen TJ, Fava M.

J Clin Psychopharmacol. 2006 Feb;26(1):56-60.

PMID:
16415707
3.

Suicidality in pediatric patients treated with antidepressant drugs.

Hammad TA, Laughren T, Racoosin J.

Arch Gen Psychiatry. 2006 Mar;63(3):332-9.

PMID:
16520440
4.

Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses.

Sinyor M, Levitt AJ, Cheung AH, Schaffer A, Kiss A, Dowlati Y, Lanctôt KL.

J Clin Psychiatry. 2010 Mar;71(3):270-9. doi: 10.4088/JCP.08r04516blu. Review.

PMID:
20122371
5.

Natural course and placebo response in short-term, placebo-controlled studies in major depression: a meta-analysis of published and non-published studies.

Storosum JG, Elferink AJ, van Zwieten BJ, van den Brink W, Huyser J.

Pharmacopsychiatry. 2004 Jan;37(1):32-6.

PMID:
14750046
6.

Placebo control groups in trials of major depressive disorder among older patients.

Walsh BT, Sysko R.

J Clin Psychopharmacol. 2005 Aug;25(4 Suppl 1):S29-33. Review.

PMID:
16027558
7.

Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.

Henkel V, Seemüller F, Obermeier M, Adli M, Bauer M, Mundt C, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Mayr A, Möller HJ, Riedel M.

J Affect Disord. 2009 Jun;115(3):439-49. doi: 10.1016/j.jad.2008.10.011.

PMID:
19027961
8.

[Antidepressants and their onset of action: a major clinical, methodological and pronostical issue].

Gourion D.

Encephale. 2008 Jan;34(1):73-81. doi: 10.1016/j.encep.2007.12.001. Review. French.

PMID:
18514154
9.

Major depressive disorder in children and adolescents: clinical trial design and antidepressant efficacy.

Emslie GJ, Ryan ND, Wagner KD.

J Clin Psychiatry. 2005;66 Suppl 7:14-20. Review.

10.

Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD.

Papakostas GI, Fava M.

Eur Neuropsychopharmacol. 2009 Jan;19(1):34-40. doi: 10.1016/j.euroneuro.2008.08.009. Review.

PMID:
18823760
11.

Which factors predict placebo response in anxiety disorders and major depression? An analysis of placebo-controlled studies of escitalopram.

Stein DJ, Baldwin DS, Dolberg OT, Despiegel N, Bandelow B.

J Clin Psychiatry. 2006 Nov;67(11):1741-6. Review.

PMID:
17196054
12.

Baseline severity of depression predicts antidepressant drug response relative to escitalopram.

Kilts CD, Wade AG, Andersen HF, Schlaepfer TE.

Expert Opin Pharmacother. 2009 Apr;10(6):927-36. doi: 10.1517/14656560902849258 .

PMID:
19317630
13.

Psychopharmacologic treatment of pediatric major depressive disorder.

Boylan K, Romero S, Birmaher B.

Psychopharmacology (Berl). 2007 Mar;191(1):27-38. Review.

PMID:
16896960
14.

The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.

Bauer M, Tharmanathan P, Volz HP, Moeller HJ, Freemantle N.

Eur Arch Psychiatry Clin Neurosci. 2009 Apr;259(3):172-85. doi: 10.1007/s00406-008-0849-0.

PMID:
19165525
15.

Placebo response and antidepressant response.

Alexopoulos GS, Kanellopoulos D, Murphy C, Gunning-Dixon F, Katz R, Heo M.

Am J Geriatr Psychiatry. 2007 Feb;15(2):149-58.

PMID:
17272735
16.

Suicide rates in short-term randomized controlled trials of newer antidepressants.

Hammad TA, Laughren TP, Racoosin JA.

J Clin Psychopharmacol. 2006 Apr;26(2):203-7.

PMID:
16633153
17.

Severe depression and antidepressants: focus on a pooled analysis of placebo-controlled studies on agomelatine.

Montgomery SA, Kasper S.

Int Clin Psychopharmacol. 2007 Sep;22(5):283-91.

PMID:
17690597
18.

Pretreatment neurophysiological and clinical characteristics of placebo responders in treatment trials for major depression.

Leuchter AF, Morgan M, Cook IA, Dunkin J, Abrams M, Witte E.

Psychopharmacology (Berl). 2004 Dec;177(1-2):15-22.

PMID:
15252704
19.

Review of the efficacy and safety of antidepressants in youth depression.

Cheung AH, Emslie GJ, Mayes TL.

J Child Psychol Psychiatry. 2005 Jul;46(7):735-54. Review.

PMID:
15972068
20.

Evaluation of structural models to describe the effect of placebo upon the time course of major depressive disorder.

Shang EY, Gibbs MA, Landen JW, Krams M, Russell T, Denman NG, Mould DR.

J Pharmacokinet Pharmacodyn. 2009 Feb;36(1):63-80. doi: 10.1007/s10928-009-9110-3.

PMID:
19205853
Items per page

Supplemental Content

Support Center